Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer

Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer deaths worldwide. Besides common therapeutic approaches, such as surgery, chemotherapy, and radiotherapy, novel therapeutic approaches, including immunotherapy, have been an advent in CRC treatment. The im...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ke-Tao, Chen, Bo, Liu, Yu-Yao, Lan, H uan-Rong, Yan, Jie-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851946/
https://www.ncbi.nlm.nih.gov/pubmed/33522929
http://dx.doi.org/10.1186/s12935-021-01763-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851946/
https://www.ncbi.nlm.nih.gov/pubmed/33522929
http://dx.doi.org/10.1186/s12935-021-01763-9

Ejemplares similares